Alex Zhavoronkov, PhD, founder and co-CEO of Insilico Medicine will be attending the AAIH Annual Members’ Meeting on the Genentech Campus in South San Francisco, California (IMAGE)

InSilico Medicine

Alex Zhavoronkov, PhD, founder and co-CEO of Insilico Medicine will be attending the AAIH Annual Members’ Meeting on the Genentech Campus in South San Francisco, California

Caption

He will be sharing his insights on the panel “Pharma Drug Discovery & ​Development AI Strategy” on 3:30 p.m, Sep. 30. All those interested are encouraged to register at https://aaihmembermeeting.org/.

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.